NO169819C - Fremgangsmaate for fremstilling av hybrid polypeptid og dna-molekyl for bruk i denne - Google Patents

Fremgangsmaate for fremstilling av hybrid polypeptid og dna-molekyl for bruk i denne

Info

Publication number
NO169819C
NO169819C NO853400A NO853400A NO169819C NO 169819 C NO169819 C NO 169819C NO 853400 A NO853400 A NO 853400A NO 853400 A NO853400 A NO 853400A NO 169819 C NO169819 C NO 169819C
Authority
NO
Norway
Prior art keywords
procedure
dna molecule
hybrid polypeptide
preparing hybrid
preparing
Prior art date
Application number
NO853400A
Other languages
English (en)
Norwegian (no)
Other versions
NO853400L (no
NO169819B (no
Inventor
James Francis Young
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of NO853400L publication Critical patent/NO853400L/no
Publication of NO169819B publication Critical patent/NO169819B/no
Publication of NO169819C publication Critical patent/NO169819C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/40Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO853400A 1984-08-30 1985-08-29 Fremgangsmaate for fremstilling av hybrid polypeptid og dna-molekyl for bruk i denne NO169819C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64573284A 1984-08-30 1984-08-30

Publications (3)

Publication Number Publication Date
NO853400L NO853400L (no) 1986-03-03
NO169819B NO169819B (no) 1992-05-04
NO169819C true NO169819C (no) 1992-08-12

Family

ID=24590246

Family Applications (1)

Application Number Title Priority Date Filing Date
NO853400A NO169819C (no) 1984-08-30 1985-08-29 Fremgangsmaate for fremstilling av hybrid polypeptid og dna-molekyl for bruk i denne

Country Status (20)

Country Link
EP (1) EP0176493B1 (d)
JP (1) JPS6169731A (d)
KR (1) KR860001882A (d)
AR (1) AR241713A1 (d)
AT (1) ATE63462T1 (d)
AU (1) AU592954B2 (d)
DE (1) DE3582843D1 (d)
DK (1) DK389085A (d)
ES (1) ES8800358A1 (d)
FI (1) FI85811C (d)
GR (1) GR852079B (d)
HU (1) HU196131B (d)
IE (1) IE58488B1 (d)
IL (1) IL76236A0 (d)
NO (1) NO169819C (d)
NZ (1) NZ213249A (d)
PH (1) PH27147A (d)
PT (1) PT81061B (d)
ZA (1) ZA856467B (d)
ZW (1) ZW13485A1 (d)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803072A (en) * 1986-09-10 1989-02-07 Smithkline Beckman Corporation Immunomodulation
NZ219515A (en) * 1987-02-10 1989-09-27 Wellcome Found Fusion proteins comprising influenza virus ha and a nonnatural antigenic epitope
AU640348B2 (en) * 1988-08-31 1993-08-26 Smithkline Beecham Corporation Vaccinal Polypeptides
ZA896625B (en) * 1988-08-31 1990-09-26 Smithkline Beecham Corp Vaccinal polypeptides
DK425789A (da) * 1988-08-31 1990-03-01 Smithkline Beecham Corp Vaccinale polypeptider
AU8501191A (en) * 1990-08-08 1992-03-02 University Of Massachusetts Medical Center Cross-reactive influenza a immunization
US5766601A (en) * 1990-08-08 1998-06-16 University Of Massachusetts Medical Center Cross-reactive influenza a immunization
WO1994022917A1 (en) * 1993-04-05 1994-10-13 University Of Massachusetts Medical Center Cross-reactive influenza a immunization
EP1659178B1 (en) 1998-02-05 2010-03-31 GlaxoSmithKline Biologicals SA A process for the purification or production of a MAGE protein
RU2164148C1 (ru) * 2000-08-09 2001-03-20 Петров Рэм Викторович Вакцина против вируса гриппа и способ ее получения

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4357421A (en) 1979-04-02 1982-11-02 G. D. Searle & Co. Synthetic gene coding for influenza hemagglutinin
IL61904A (en) * 1981-01-13 1985-07-31 Yeda Res & Dev Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same
ZA836080B (en) * 1982-08-23 1984-04-25 Scripps Clinic Res Broad spectrum influenza antisera
CA1340372C (en) * 1984-07-09 1999-02-02 John D. Clements Production of e. coli lt-b enterotoxin subunit

Also Published As

Publication number Publication date
FI853320L (fi) 1986-03-01
DK389085D0 (da) 1985-08-27
EP0176493A1 (en) 1986-04-02
NO853400L (no) 1986-03-03
AU592954B2 (en) 1990-02-01
NO169819B (no) 1992-05-04
GR852079B (d) 1985-12-23
ES8800358A1 (es) 1987-11-01
HUT39362A (en) 1986-09-29
EP0176493B1 (en) 1991-05-15
PT81061A (en) 1985-09-01
FI85811C (fi) 1992-06-10
NZ213249A (en) 1989-03-29
DK389085A (da) 1986-03-01
PT81061B (pt) 1987-11-11
ZW13485A1 (en) 1985-11-20
DE3582843D1 (de) 1991-06-20
PH27147A (en) 1993-04-02
ATE63462T1 (de) 1991-06-15
ZA856467B (en) 1986-07-30
AR241713A1 (es) 1992-11-30
FI853320A0 (fi) 1985-08-29
IE852103L (en) 1986-02-28
AU4668585A (en) 1986-03-06
KR860001882A (ko) 1986-03-24
JPS6169731A (ja) 1986-04-10
HU196131B (en) 1988-10-28
IE58488B1 (en) 1993-09-22
FI85811B (fi) 1992-02-28
IL76236A0 (en) 1986-01-31
ES546530A0 (es) 1987-11-01

Similar Documents

Publication Publication Date Title
FI874787A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten nor-statiini- ja nor-syklostatiinipolypeptidien valmistamiseksi
EP0243929A3 (en) Polypeptide and protein derivatives and process for their preparation
DK100985D0 (da) Dna, der koder for human tumornecrosefaktor, samt humant tumornecrosefaktor-polypeptid og fremgangsmaader til fremstilling heraf
JPS56150100A (en) Manufacture of dna order,recombination dna molecule and human interferon-like polypeptide
CY1346A (en) Dna sequences,recombinant dna molecules and processes for producing human interferon-like polypeptides
DK166087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
DK496486D0 (da) Polypeptid
PT79917B (en) Process for preparing new renin- inhibotory peptides and their use
PT87688A (pt) Hybrid protein c and method for its preparation
IL81839A0 (en) Polypeptide,dna and its use
ZA86217B (en) Dna sequences,recombinant dna molecules and processes for producing human lipocortin-like polypeptides
IL91234A0 (en) Hybrid protein c constructs and methods for their preparation
DK454882A (da) Rekombinante dna-klonende vektorer til anvendelse i streptomyces og dermed beslaegtede organismer
NO169819C (no) Fremgangsmaate for fremstilling av hybrid polypeptid og dna-molekyl for bruk i denne
EP0209543A4 (en) FRAGMENTS OF HUMAN APOLIPOPROTEINS PEPTIDES, TYPE-SPECIFIC ANTIBODIES AND METHODS OF USE.
GB8404378D0 (en) Dna sequence recombinant dna molecules
DK551287A (da) Polypeptid
DK354389D0 (da) Polypeptid
IL83347A0 (en) Recombinant htlv-iii proteins and their use
DK460183A (da) Funktionelt uafhaengige rekombinante dna-klonende vektorer til anvendelse i streptomyces
FI871607L (fi) Menetelmä peptidien valmistamiseksi, menetelmässä käyttökelpoinen yhdistelmäplasmidi ja plasmidilla transformoituja myeloomasoluja
ZA888733B (en) Peptide structures,immunogens containing them and their uses in the control of fertility
DE3682358D1 (de) Expressionsvektoren zur verwendung in e. coli.
EP0170266A3 (en) Process for producing protein, and vector, recombinant dna and transformant used therefor
EP0199018A3 (en) Expression in e.coli of hybrid polypeptides containing the growth hormone releasing factor sequence